Atlas Trials

Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection

Clinical trial NCT01147107 · COMPLETED

Trial details

NCT number
NCT01147107
Sponsor
University of Hawaii
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis C, ChronicHIV Infection
Start date
2014-02-01
Primary completion
2016-06-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.